Clearside Biomedical Inc (CLSD) Insider Trading

Total insider buys:
  • $5,911,749.57
Total insider sells:
  • $10,253,417.17
Most recent insider trade:
  • April 17, 2024
Most active insider trader:
  • Clay Thorp
Trader NameDateTitleAmountPriceTypeTotal Value
April 17, 2024Director6,710$1.25Buy$8,387.50
March 20, 2024Insider30,000$1.60Buy$48,000.00
Feb. 7, 2024Major Shareholder444,444$1.35Buy$599,999.40
Jan. 19, 2024CEO18,000$1.27Sell$22,860.00
Jan. 19, 2024CFO12,900$1.28Sell$16,512.00
Nov. 1, 2023Major Shareholder64,366$0.74Buy$47,630.84
Oct. 30, 2023Major Shareholder600$0.69Buy$414.00
Oct. 3, 2023Director10,000$0.86Buy$8,600.00
Sept. 25, 2023Director10,000$0.86Buy$8,600.00
Jan. 20, 2023Insider13,700$1.47Sell$20,139.00
Jan. 19, 2023CFO14,030$1.50Sell$21,045.00
Jan. 19, 2023CEO20,030$1.46Sell$29,243.80
Jan. 10, 2023Insider2,170$1.62Sell$3,515.40
Dec. 21, 2022Director14,000$1.02Buy$14,280.00
Nov. 17, 2022Director30,000$1.33Buy$39,900.00
Jan. 19, 2022Insider9,050$2.13Sell$19,276.50
Jan. 19, 2022CEO10,800$2.12Sell$22,896.00
Jan. 19, 2022CFO8,833$2.09Sell$18,460.97
Jan. 11, 2022CEO5,100$2.46Sell$12,546.00
Sept. 21, 2021CFO2,800$6.41Sell$17,948.00
Sept. 21, 2021CEO3,525$6.46Sell$22,771.50
Sept. 21, 2021Insider2,560$6.40Sell$16,384.00
Sept. 1, 2021Major Shareholder213,203$6.89Sell$1,468,968.67
Aug. 30, 2021Major Shareholder99,400$7.06Sell$701,764.00
June 21, 2021CEO3,707$4.38Sell$16,236.66
June 21, 2021CFO2,938$4.37Sell$12,839.06
March 19, 2021CEO3,370$2.82Sell$9,503.40
Feb. 10, 2021Director32,873$4.43Sell$145,627.39
Jan. 6, 2021Major Shareholder350,750$2.85Buy$999,637.50
Dec. 24, 2020Major Shareholder51,195$1.95Buy$99,830.25
Dec. 2, 2020Major Shareholder53,900$1.95Buy$105,105.00
Nov. 24, 2020Major Shareholder62,000$1.65Buy$102,300.00
Nov. 16, 2020Major Shareholder62,000$1.69Buy$104,780.00
Sept. 22, 2020CEO13,411$1.59Sell$21,323.49
Aug. 18, 2020Director5,586$1.78Buy$9,943.08
Aug. 12, 2020Major Shareholder300,000$1.63Buy$489,000.00
May 20, 2020Director5,000$1.88Buy$9,400.00
May 12, 2020CEO32,150$1.99Sell$63,978.50
Nov. 12, 2019CFO7,500$1.14Buy$8,550.00
Nov. 11, 2019CEO12,000$1.16Buy$13,920.00
March 15, 2019CFO10,000$1.36Buy$13,600.00
Dec. 6, 2018Director8,000$1.36Buy$10,880.00
June 4, 2018Insider11,000$9.07Buy$99,770.00
May 18, 2018Director161,139$13.08Sell$2,107,698.12
March 23, 2018CFO500$11.79Buy$5,895.00
March 22, 2018Director7,500$11.89Buy$89,175.00
Dec. 7, 2017Director5,000$6.13Sell$30,650.00
Dec. 5, 2017Director15,000$6.37Sell$95,550.00
Nov. 16, 2017Director35,000$7.00Sell$245,000.00
Nov. 14, 2017Director15,000$7.02Sell$105,300.00
First«1 of 2»Last
  • Insiders are both buying and selling Clearside Biomedical Inc stock.

  • The insider traders at Clearside Biomedical Inc are: Clay Thorp, Daniel H White, Bradford T Whitmore, George M Lasezkay, Charles A Deignan, Thomas Ciulla, Christy L Shaffer, Nancy J Hutson, Gerald D Cagle, William D Humphries, Bradford T. Whitmore, George M. Lasezkay, Ngai Hang Victor Chong, Venture Advisors Iii Hatteras, Venture Advisors Iv S Hatteras, and Anthony S Gibney

  • The most active insider trader at Clearside Biomedical Inc is Clay Thorp with 28 trades.

  • Clay Thorp has sold the most Clearside Biomedical Inc stock with a total value of $7,099,536.98.

  • Venture Advisors Iv S Hatteras has bought the most Clearside Biomedical Inc stock with a total value of $5,800,004.00.

  • The most recent insider trade for Clearside Biomedical Inc was on April 17, 2024.

  • The single biggest insider buy for Clearside Biomedical Inc was from Venture Advisors Iv S Hatteras with a total value of $2,900,002.00 on June 7, 2016.

  • The single biggest insider sell for Clearside Biomedical Inc was from Clay Thorp with a total value of $2,107,698.12 on May 18, 2018.